WT1 gene expression in children with Down syndrome and transient myeloproliferative disorder

Leukemia Research

Volumn 30, Issue 5, 2006, Pages 543-546

  Hasle, Henrik ^a   Lund, Bendik ^b   Nyvold, Charlotte Guldborg ^a   Hokland, Peter ^a   Østergaard, Mette ^a,c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c VIBORG HOSPITAL   (Denmark)

Author keywords

Down syndrome; Minimal residual disease; Transient myeloproliferative disorder; WT1

Indexed keywords

TRANSCRIPTION FACTOR GATA 1; WT1 PROTEIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOWN SYNDROME; FEMALE; GENE EXPRESSION; HUMAN; INFANT; LEUKEMIA; LONGITUDINAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MYELOPROLIFERATIVE DISORDER; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION;

ACUTE DISEASE; CYTARABINE; DOWN SYNDROME; FEMALE; FOLLOW-UP STUDIES; GATA1 TRANSCRIPTION FACTOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; GENES, WILMS TUMOR; HUMANS; INFANT, NEWBORN; LEUKEMIA, MYELOID; LONGITUDINAL STUDIES; MALE; MUTATION; MYELOPROLIFERATIVE DISORDERS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

EID: 33644849504     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2005.09.010     Document Type: Article

References (19)

1. H. Hasle, I.H. Clemmensen, and M. Mikkelsen Risks of leukemia and solid tumours in individuals with Down's syndrome Lancet 355 2000 165 169
2. A. Zipursky, E. Brown, H. Christensen, R. Sutherland, and J. Doyle Leukemia and/or myeloproliferative syndrome in neonates with Down syndrome Semin Perinatol 21 1997 97 101
3. G.V. Massey Transient leukemia in newborns with Down syndrome Pediatr Blood Cancer 44 2005 29 32
4. U. Creutzig, J. Ritter, J. Vormoor, W.D. Ludwig, C. Niemeyer, and I. Reinisch Myelodysplasia and acute myelogenous leukemia in Down's syndrome. A report of 40 children of the AML-BFM Study Group Leukemia 10 1996 1677 1686
5. A. Zipursky Transient leukemia - a benign form of leukemia in newborn infants with trisomy 21 Br J Haematol 120 2003 930 938
6. Y. Ravindranath Down syndrome and leukemia: new insights into the epidemiology, pathogenesis, and treatment Pediatr Blood Cancer 44 2005 1 7
7. H. Hasle, C.M. Niemeyer, J.M. Chessells, I. Baumann, J.M. Bennett, and G. Kerndrup A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases Leukemia 17 2003 277 282
8. J. Wechsler, M. Greene, M.A. McDevitt, J. Anastasi, J.E. Karp, and M.M. Le Beau Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome Nat Genet 32 2002 148 152
9. G. Mundschau, S. Gurbuxani, A.S. Gamis, M.E. Greene, R.J. Arceci, and J.D. Crispino Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis Blood 101 2003 4298 4300
10. L. Rainis, D. Bercovich, S. Strehl, A. Teigler-Schlegel, B. Stark, and J. Trka Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21 Blood 102 2003 981 986
11. M. Ahmed, A. Sternberg, G. Hall, A. Thomas, O. Smith, and A. O'Marcaigh Natural history of GATA1 mutations in Down syndrome Blood 103 2004 2480 2489
12. J. Groet, S. McElwaine, M. Spinelli, A. Rinaldi, I. Burtscher, and C. Mulligan Acquired mutations in GATA1 in neonates with Down's syndrome with transient myeloid disorder Lancet 361 2003 1617 1620
13. G. Xu, M. Nagano, R. Kanezaki, T. Toki, Y. Hayashi, and T. Taketani Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome Blood 102 2003 2960 2968
14. M. Hellebostad, E. Carpenter, H. Hasle, C. Mitchell, and P. Vyas GATA1 mutation analysis demonstrates two distinct primary leukemias in a child with Down syndrome; implications for leukemogenesis J Pediatr Hematol Oncol 27 2005 408 409
15. J. Trka, M. Kalinova, O. Hrusak, J. Zuna, O. Krejci, and J. Madzo Real-time quantitative PCR detection of WT1 gene expression in children with AML: prognostic significance, correlation with disease status and residual disease detection by flow cytometry Leukemia 16 2002 1381 1389
16. M. Østergaard, L.H. Olesen, H. Hasle, E. Kjeldsen, and P. Hokland WT1 gene expression: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukemia patients - results from a single-centre study Br J Haematol 125 2004 590 600
17. J.K. Hitzler, J. Cheung, Y. Li, S.W. Scherer, and A. Zipursky GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome Blood 101 2003 4301 4304
18. S.R. Pine, Q. Guo, C. Yin, S. Jayabose, O. Levendoglu-Tugal, and M.F. Ozkaynak GATA1 as a new target to detect minimal residual disease in both transient leukemia and megakaryoblastic leukemia of Down syndrome Leuk Res 29 2005 1353 1356
19. J. Hitzler, and A. Zipursky GATA1 mutations as clonal markers of minimal residual disease in acute megakaryoblastic leukemia of Down syndrome - a new tool with significant potential applications Leuk Res 29 2005 1239 1240